Europe Neurostimulation Devices Market Forecast to 2030 - Regional Analysis

Description

List of Tables

The Europe neurostimulation devices market was valued at US$ 1,717.84 million in 2022 and is expected to reach US$ 3,459.24 million by 2030; it is estimated to register a CAGR of 9.1% from 2022 to 2030.

Rising Cases of Spinal Cord Injury Fuel Europe Neurostimulation Devices Market

The neurostimulation devices industry has gained traction owing to the rising elderly population prone to various spinal disorders. These population is becoming more susceptible to developing spinal disorders such as degenerative disc diseases, osteoarthritis, scoliosis, spinal tumor, and spinal stenosis. As this population ages, the natural wear and tear of the spine can lead to several spinal disorders. Hence, with this fact, the aging population poses a unique challenge to spine surgeons due to multiple increased frailty, medical comorbidities, decreased nutritional status, and the higher probability of postoperative complications. According to the World Health Organization (WHO) data published in October 2022, approximately 80% of the elderly population will be living in low-and middle-income countries by 2050, and it is anticipated that the pace of this population aging will be much faster than in the past. The aging demographic, coupled with lifestyle-related factors has led to a substantial increase in individuals experiencing spinal issues such as degenerative disc disease and spinal deformities. Therefore, high incidence of spinal cord injuries in old age and adults stimulates the demand for neurostimulation devices.

Europe Neurostimulation Devices Market Overview

The Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The regional market is expected to grow significantly in the coming years owing to the rising prevalence of neurologic disorders such as cerebral aneurysms, stroke, and others and increasing product innovations made by the market players operating in the region. The market growth is also attributed to the development of healthcare systems in countries such as Germany, France, and Spain and rise in innovative product launches by key regional companies. In June 2020, Medtronic announced the launch of the PerceptTM PC Neurostimulator with BrainsenseTM technology. The technology simultaneously records and delivers electrical stimulations to the brain to relieve symptoms of Parkinson's disease (PD).

Europe Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

Europe Neurostimulation Devices Market Segmentation

The Europe neurostimulation devices market is segmented based on product, application, end user, and country.

Based on product, the Europe neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the Europe neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held the largest market share in 2022.

By end user, the Europe neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, ElectroCore Inc, and Mainstay Medical are some of the leading companies operating in the Europe neurostimulation devices market.

Product Code: BMIRE00030035

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Neurological Disorders
- 4.1.2 Rising Cases of Spinal Cord Injury
4.2 Market Restraints
- 4.2.1 Lack of Expert Professionals
4.3 Market Opportunities
- 4.3.1 Growing Advances and Approvals for Neurostimulation Devices
4.4 Future Trends
- 4.4.1 Rising Demand for Noninvasive Treatment
4.5 Impact Analysis

5. Neurostimulation Devices Market - Europe Market Analysis

5.1 Europe Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Spinal Cord Stimulator
- 6.3.1 Overview
- 6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Deep Brain Stimulator
- 6.4.1 Overview
- 6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Sacral Nerve Stimulator
- 6.5.1 Overview
- 6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vagus Nerve Stimulator
- 6.6.1 Overview
- 6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Pain Management
- 7.3.1 Overview
- 7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Epilepsy
- 7.4.1 Overview
- 7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Urinary and Fecal Incontinence
- 7.5.1 Overview
- 7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Parkinson's Disease
- 7.6.1 Overview
- 7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Specialty Clinics
- 8.4.1 Overview
- 8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Europe: Neurostimulation Devices Market
- 9.1.1 Overview
- 9.1.2 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 9.1.2.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview
10.3 Inorganic Developments
- 10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Boston Scientific Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Nevro Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 LivaNova Plc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Synapse Biomedical Inc.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 ElectroCore Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Mainstay Medical
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms